ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia

Vertex Pharmaceuticals Incorporated · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
crispr-cas9genetic-diseases
beta-thalassemia, thalassemia, genetic diseases, inborn, hematologic diseases, hemoglobinopathies, crispr-cas9, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 892461
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.